Markets

ORIC Pharmaceuticals Stock Rated Buy by H.C. Wainwright

Published on 6/8/2026

#ORIC#Buy#Stock#Pharmaceuticals
ORIC Pharmaceuticals Stock Rated Buy by H.C. Wainwright

AI Summary

Summarized by AI from the source below

H.C. Wainwright has reiterated a Buy rating on ORIC Pharmaceuticals (ORIC). This endorsement reflects confidence in the company's growth potential within the pharmaceutical sector. The impact of this rating may influence trading volumes as investors may respond favorably to this affirmation. No specific price targets or trading metrics were provided in the report.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

GE HealthCare (GEHC) and Medtronic (MDT) Options Bets Recommend Decline
Markets

GE HealthCare (GEHC) and Medtronic (MDT) Options Bets Recommend Decline

Sep 4

Volkswagen (VWAGY) Plans 50,000 Job Cuts Amid 8% Share Surge
Markets

Volkswagen (VWAGY) Plans 50,000 Job Cuts Amid 8% Share Surge

Sep 4

Stocks Making Big Moves: AMC, USA Rare Earth, Lululemon, Adobe
Markets

Stocks Making Big Moves: AMC, USA Rare Earth, Lululemon, Adobe

Sep 4

Norway's Sovereign Wealth Fund Plans to Cut U.S. Treasury Holdings
Markets

Norway's Sovereign Wealth Fund Plans to Cut U.S. Treasury Holdings

Sep 4